Hui Zhang | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Hui Zhang | Clinical Neuroscience | Best Researcher Award

Prof. Hui Zhang | Northwestern University | United States

Hui Zhang is a Professor in the Division of Biostatistics, Department of Preventive Medicine at Northwestern University Feinberg School of Medicine, where he also holds appointments at the Robert H. Lurie Comprehensive Cancer Center, the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease, and the Center for Epidemiology and Population Health. he serves as Director of the Northwestern Brain Tumor SPORE Biostatistics and Bioinformatics Core and leads the Biostatistics and Data Management Core at the Mesulam Center. With a Ph.D. in Statistics from the University of Rochester, her academic foundation spans pharmacology, neurophysiology, and biology, reflecting her interdisciplinary expertise in biostatistics and biomedical research. His previous experience includes research roles at St. Jude Children’s Research Hospital, where she contributed significantly to clinical and statistical protocol development. Professor Zhang’s work focuses on statistical methodologies for cancer and neurological disease research, data integration, and bioinformatics applications. he is an active member of several professional societies, including the American Statistical Association and the International Chinese Statistical Association. A highly cited researcher, she has accumulated over 11,422 citations, an h-index of 43, and an i10-index of 100, demonstrating her substantial impact and leadership in the fields of biostatistics and medical data science.

Profile: Google Scholar

Featured Publications

Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., et al. (2009). Cardiac-resynchronization therapy for the prevention of heart-failure events. New England Journal of Medicine, 361(14), 1329–1338.

Gunzler, D., Chen, T., Wu, P., & Zhang, H. (2013). Introduction to mediation analysis with structural equation modeling. Shanghai Archives of Psychiatry, 25(6), 390–394.

Wan, T., Jun, H. U., Pan, W. U., & Hua, H. E. (2015). Kappa coefficient: A popular measure of rater agreement. Shanghai Archives of Psychiatry, 27(1), 62–67.

Pu, J., Wang, S., Yin, Y., Zhang, G., Carter, R. A., Wang, J., Xu, G., Sun, H., Wang, M., et al. (2015). Evolution of the H9N2 influenza genotype that facilitated the genesis of the novel H7N9 virus. Proceedings of the National Academy of Sciences, 112(2), 548–553.

Guy, C. S., Vignali, K. M., Temirov, J., Bettini, M. L., Overacre, A. E., Smeltzer, M., et al. (2013). Distinct TCR signaling pathways drive proliferation and cytokine production in T cells. Nature Immunology, 14(3), 262–270.

Shen, S., Chen, X., Cai, J., Yu, J., Gao, J., Hu, S., Zhai, X., Liang, C., Ju, X., Jiang, H., et al. (2020). Effect of dasatinib vs imatinib in the treatment of pediatric Philadelphia chromosome–positive acute lymphoblastic leukemia: A randomized clinical trial. JAMA Oncology, 6(3), 358–366.

Sonabend, A. M., Gould, A., Amidei, C., Ward, R., Schmidt, K. A., Zhang, D. Y., et al. (2023). Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: A phase 1 trial. The Lancet Oncology, 24(5), 509–522.

Kathrin Eichinger | Clinical Neuroscience | Outstanding Contribution Award

Published on by Neuroscientists

Dr. Kathrin Eichinger | Clinical Neuroscience | Outstanding Contribution Award 

Dr. Kathrin Eichinger | Medizinische Universitat Wien | Austria

Dr. Med. Kathrin Eichinger is an Austrian physician specializing in Pediatrics and Pediatric Neurology, currently serving as a Consultant in Child and Adolescent Medicine with subspecialty training in Neuropediatrics at the Medical University of Vienna. Her clinical and academic focus lies in neuroimmunology, with ongoing doctoral research in neuroscience examining acute necrotizing encephalitis. Dr. Eichinger’s experience spans several leading medical institutions, including Sankt Anna Children’s Hospital and the Hospital of the Brothers of Mercy in Eisenstadt, complemented by an observership in Neurointensive Care and Neuroimmunology at the Children’s Hospital of Philadelphia. She has also contributed to clinical research through her involvement in the eSMART randomized controlled trial on electronic symptom management at the Medical University of Vienna. Her expertise is further supported by certification in pediatric EEG and active participation in numerous neuropediatric congresses and workshops across Europe. Multilingual in German, English, and Spanish, Dr. Eichinger combines her clinical acumen with strong research engagement, reflected in her growing academic footprint with an h-index of 3, five peer-reviewed documents, and approximately 45 citations. Her professional pursuits integrate advanced clinical training, translational neuroscience, and a dedication to improving pediatric neurocare.

Profile: Orcid

Featured Publications

  • Eichinger, K., Breu, M., Renken, M., Siegert, S., Hilz, E., Glatter, S., Csaicsich, D., Boehm, M., Lechner, C., Kornek, B., et al. (2025). Complications of therapeutic plasma exchange in pediatric neuroimmune disorders. Children, 12(11), 1457.

  • Grasl, S., Janik, S., Dressler, A., Diehm, R., Gröppel, G., Eichinger, K., Grasl, M. C., Gstoettner, W., Feucht, M., Vyskocil, E., et al. (2021). Management and outcome of vagus nerve stimulator implantation: Experience of an otolaryngeal/neuropediatric cooperation. European Archives of Oto-Rhino-Laryngology, 278(10), 3729–3738.

Seyyed Ali Zendehbad | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Seyyed Ali Zendehbad | Clinical Neuroscience | Best Researcher Award

Dr. Seyyed Ali | Zendehbad University of Mazandaran | Iran

Dr. Seyyed Ali Zendehbad is a multidisciplinary researcher specializing in biomedical signal processing, cognitive computational neuroscience, and neurorehabilitation technologies. His research integrates deep learning, pattern recognition, and multimodal biological data modeling to enhance fatigue detection and neurorehabilitation systems. He has authored several peer-reviewed papers in reputable journals such as Scientific Reports, IEEE Access, Sensing and Bio-Sensing Research, and Healthcare Technology Letters, focusing on hybrid AI frameworks, EMG signal processing, and muscle synergy-based biofeedback mechanisms. Dr. Zendehbad’s work on developing intelligent rehabilitation systems, including his models like TraxVBF and FatigueNet, contributes to advancing telemonitoring and assistive technologies for neurological recovery. His scholarly output includes more than 25 documents, over 600 citations, and an h-index of 12, reflecting his growing impact in computational neuroscience and biomedical engineering. Recognized for innovation, he has achieved first-place awards in multiple national startup competitions and was honored with the Best Poster Award at the Congress of Neurology and Clinical Electrophysiology of Iran. As a postdoctoral researcher at the University of Mazandaran, his ongoing work emphasizes integrating trustworthy AI into telehealth systems, promoting equitable and efficient digital healthcare delivery through interdisciplinary research and technological innovation.

Profile: Orcid

Featured Publications

1. Mazrooei Rad, E., Mazinani, S. M., & Zendehbad, S. A. (2025). Diagnosis of Alzheimer’s disease using non-linear features of ERP signals through a hybrid attention-based CNN-LSTM model. Computer Methods and Programs in Biomedicine Update, 5, 100192.

2. Zendehbad, S. A., Sharifi Razavi, A., Tabrizi, N., & Sedaghat, Z. (2025). A systematic review of artificial intelligence techniques based on electroencephalography analysis in the diagnosis of epilepsy disorders: A clinical perspective. Epilepsy Research, 207, 107582.

3. Mazrooei Rad, E., Zendehbad, S. A., & Hosseinzadeh, V. (2025). Fetal QRS complex detection based on adaptive filters and peak detection. Research on Biomedical Engineering, 41(3), 424–438.

4. Zendehbad, S. A., Ghasemi, J., & Samsami Khodadad, F. (2025). FatigueNet: A hybrid graph neural network and transformer framework for real-time multimodal fatigue detection. Scientific Reports, 15(1), 640.

5. Safdel, A., Zendehbad, S. A., & Ghasemi, J. (2025). Advanced deep learning approaches for accurate and efficient suspicious behavior detection in surveillance videos. Computational Sciences and Engineering, 21(2), 1099.

Chun-An Cheng | Translational Neuroscience | Lifetime achievement Award

Published on by Neuroscientists

Assist. Prof. Dr. Chun-An Cheng | Translational Neuroscience | Lifetime achievement Award

Assist. Prof. Dr. Chun-An Cheng | Tri-Service General Hospital | Taiwan

Assistant Professor Dr. Chun-An Cheng is a distinguished researcher affiliated with the Tri-Service General Hospital, Taiwan, known for his significant contributions to medical and clinical research. He has authored 73 scholarly documents, which have collectively garnered 658 citations across 620 publications, reflecting the wide impact and recognition of his scientific work. With an h-index of 14, Dr. Cheng has demonstrated consistent research productivity and influence within his field. His research encompasses multidisciplinary areas in clinical medicine, focusing on advancing diagnostic methodologies, therapeutic innovations, and patient-centered healthcare strategies. Through his collaborations and publications, Dr. Cheng has contributed to improving the understanding of complex medical conditions and enhancing evidence-based clinical practices. His dedication to translational research bridges the gap between laboratory findings and clinical applications, reinforcing his role as a key figure in the Taiwanese medical research community. Dr. Cheng continues to drive impactful studies that promote innovation, patient safety, and improved health outcomes, positioning him as a leading voice in contemporary clinical science.

Profiles: Scopus | Orcid | Research Gate

Featured Publications

  • (2025). Effects of exposure to air pollution and cold weather on acute myocardial infarction mortality. Atmosphere.

  • (2025). The risk of ischemic stroke in patients with chronic obstructive pulmonary disease and atrial fibrillation. Life.

  •  (2024). Increased risk of psychiatric disorder in patients with hearing loss: A nationwide population-based cohort study. Journal of Translational Medicine.

  • (2024). Diabetes mellitus and gynecological and inflammation disorders increased the risk of pregnancy loss in a population study. Life.

  • (2024). The influence of fine particulate matter and cold weather on emergency room interventions for childhood asthma. Life.

  • (2024). Impact of foodborne disease in Taiwan during the COVID-19 pandemic. Medicina (Lithuania).

  • (2024). Analyzing COVID-19 and air pollution effects on pediatric asthma emergency room visits in Taiwan. Toxics.

Sofia Gandolfi | Developmental Neuroscience | Best Researcher Award

Published on by Neuroscientists

Ms. Sofia Gandolfi | Developmental Neuroscience | Best Researcher Award

Ms. Sofia Gandolfi | Fondazione IRCCS Istituto Neurologico Carlo Besta | Italy

Ms. Sofia Gandolfi is an Italian Speech and Language Therapist specializing in the assessment and management of swallowing disorders, particularly in children with neurogenic and neuromuscular conditions such as Spinal Muscular Atrophy. She has gained extensive clinical experience at the Fondazione IRCCS Istituto Neurologico Carlo Besta in Milan, where she performs swallowing screenings, clinical evaluations, and develops individualized rehabilitation plans involving therapy, compensatory strategies, and dietary recommendations in collaboration with multidisciplinary teams that include neurologists, ENT specialists, gastroenterologists, dietitians, and physiotherapists. Her work emphasizes evidence-based interventions to enhance swallowing safety, efficiency, and quality of life for patients. Sofia also has experience in assessing and treating children and adults with neurodevelopmental and neurodegenerative disorders, both in outpatient settings and home-based care. Beyond clinical practice, she has contributed to research on swallowing physiology, intervention efficacy, and quality improvement initiatives in dysphagia services. She holds a Master of Science in Clinical Speech and Language Studies with a specialization in Dysphagia from Trinity College Dublin. Her academic contributions are reflected in 1 published document, 1 citation, and an h-index of 1, demonstrating her emerging engagement in research and her commitment to advancing clinical practices in speech and swallowing therapy.

Profiles: Google Scholar | Orcid | Research Gate | Linked In

Featured Publications

Mozzanica, F., Pizzorni, N., Gitto, M., Dosi, C., Mandelli, A., Gandolfi, S., & others. (2024). Fiberoptic endoscopic evaluation of swallowing (FEES) in children with spinal muscular atrophy type 1: Feasibility, swallowing safety and efficacy, and dysphagia phenotype. European Archives of Oto-Rhino-Laryngology, 281(12), 6523–6532.

Gandolfi, S., Dosi, C., Parravicini, S., Arnoldi, M. T., Zanin, R., Biagi, S., Rinaldi, L., & others. (2025). Exploring the trajectory of swallowing within psychomotor development in spinal muscular atrophy: Moving toward integrated care. Audiology Research.

Masson, R., Dosi, C., Parravicini, S., Scopelliti, M., Arnoldi, M., Zanin, R., & others. (2025). 519P The challenge of swallowing assessment in SMA1: Dysphagia clinical features and available assessment tools. Neuromuscular Disorders, 53, 105608.

Alireza Kamali-Asl | Neuroimaging | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Alireza Kamali-Asl | Neuroimaging | Best Researcher Award

Prof. Dr. Alireza Kamali-Asl | Freelance organization | United Kingdom

Professor Alireza Kamaliasl is a distinguished expert in medical radiation engineering and serves as the Director of the Medical Imaging Instruments Laboratory and Head of Molecular Imaging Modality. With over two decades of experience in healthcare technology and molecular imaging, he has made pioneering contributions to the design, simulation, and manufacture of advanced medical imaging instruments across modalities such as SPECT, PET, CT, and radiography. His interdisciplinary research integrates mathematical modeling, computational analysis, and clinical collaboration to enhance diagnostic and theranostic imaging systems. Professor Kamaliasl has authored more than 150 publications in top-tier international journals and conferences, achieving an h-index of 28, with over 3,800 citations and 160 research documents indexed in global databases. He has successfully supervised more than 45 postgraduate research projects, fostering innovation and leadership in radiological sciences. His expertise spans radio-isotopic imaging, system performance optimization, radiation shielding, device calibration, and preventive maintenance management. Recognized for his role as a visionary mentor and strategic planner, Professor Kamaliasl continues to advance multimodality molecular imaging and medical instrumentation, bridging the gap between engineering innovation and clinical application to improve diagnostic precision and therapeutic outcomes.

Profiles: Scopus | Orcid | Google Scholar | Research Gate | Linked In

Featured Publications

  1. Habibzadeh, M. A., Ay, M. R., Kamali-Asl, A. R., Ghadiri, H., & Zaidi, H. (2012). Impact of miscentering on patient dose and image noise in X-ray CT imaging: Phantom and clinical studies. Physica Medica, 28(3), 191–199.

  2. Aghakhan Olia, N., Kamali-Asl, A., Hariri Tabrizi, S., Geramifar, P., et al. (2022). Deep learning–based denoising of low-dose SPECT myocardial perfusion images: Quantitative assessment and clinical performance. European Journal of Nuclear Medicine and Molecular Imaging, 49(5), 1508–1522.

  3. Arefan, D., Talebpour, A., Ahmadinejhad, N., & Kamali-Asl, A. (2015). Automatic breast density classification using neural network. Journal of Instrumentation, 10(12), T12002.

  4. Poorbaygi, H., Aghamiri, S. M. R., Sheibani, S., Kamali-Asl, A., et al. (2011). Production of glass microspheres comprising 90Y and 177Lu for treating hepatic tumors with SPECT imaging capabilities. Applied Radiation and Isotopes, 69(10), 1407–1414.

  5. Khazaee Moghadam, M., Kamali-Asl, A., Geramifar, P., & Zaidi, H. (2016). Evaluating the application of tissue-specific dose kernels instead of water dose kernels in internal dosimetry: A Monte Carlo study. Cancer Biotherapy and Radiopharmaceuticals, 31(10), 367–379.*

Musawer Hakimi | Systems Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mr. Musawer Hakimi | Systems Neuroscience | Best Researcher Award

Mr. Musawer Hakimi | Samangan University | Afghanistan

Mr. Musawer Hakimi is an accomplished Assistant Professor at Samangan University, specializing in Computer Science. He holds a Bachelor’s degree in Computer Science from India and a Master’s degree in Information Technology from Kabul University. Demonstrating a strong commitment to lifelong learning, he has earned 25 professional certificates in Computer Science from India, along with two specialized certifications in Ethical Hacking and Oracle Database from the United States. His academic excellence and research contributions have positioned him as a respected scholar with 3 published documents, 13 citations, and an h-index of 1. Mr. Hakimi’s scholarly work has been featured in reputable international journals across the United Kingdom, the United States, Turkey, Sweden, and Indonesia, reflecting his active engagement in global research networks. Beyond his research achievements, he is dedicated to nurturing future computer scientists through his teaching and mentorship at the Public University of Afghanistan, where he plays an instrumental role in advancing computer science education. His interdisciplinary expertise, international collaborations, and consistent scholarly output underscore his impact as an educator, researcher, and thought leader in the evolving field of computer science, contributing to the growth of academic excellence and innovation within Afghanistan and the broader global academic community.

Profiles: Scopus | Orcid | Google Scholar | Research Gate

Featured Publications

Quraishi, T., Ulusi, H., Muhid, A., Hakimi, M., & Olusi, M. R. (2024). Empowering students through digital literacy: A case study of successful integration in a higher education curriculum. Journal of Digital Learning and Distance Education, 2(9), 667–681.

Fazil, A. W., Hakimi, M., Shahidzay, A. K., & Hasas, A. (2024). Exploring the broad impact of AI technologies on student engagement and academic performance in university settings in Afghanistan. RIGGS: Journal of Artificial Intelligence and Digital Business, 2(2), 56–63.

Hakimi, M., Katebzadah, S., & Fazil, A. W. (2024). Comprehensive insights into e-learning in contemporary education: Analyzing trends, challenges, and best practices. Journal of Education and Teaching Learning (JETL), 6(1), 86–105.

Hakimi, N., Hakimi, M., Hejran, M., Quraishi, T., Qasemi, P., Ahmadi, L., & others. (2024). Challenges and opportunities of e-learning for women’s education in developing countries: Insights from Women Online University. EDUTREND: Journal of Emerging Issues and Trends in Education, 1(1), 57–69.

Hasas, A., Hakimi, M., Shahidzay, A. K., & Fazil, A. W. (2024). AI for social good: Leveraging artificial intelligence for community development. Journal of Community Service and Society Empowerment, 2(2), 196–210.

Fazil, A. W., Hakimi, M., Sajid, S., Quchi, M. M., & Khaliqyar, K. Q. (2023). Enhancing internet safety and cybersecurity awareness among secondary and high school students in Afghanistan: A case study of Badakhshan Province. American Journal of Education and Technology, 2(4), 50–61.

Alam, M. I., Khatri, S., Shukla, D. K., Misra, N. K., Satpathy, S., & Hakimi, M. (2025). Blockchain-based coal supply chain management system for thermal power plants. Discover Computing, 28(1), 1–32.

Wilfred Angie Abia | Developmental Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Wilfred Angie Abia | Developmental Neuroscience | Best Researcher Award

Dr. Wilfred Angie Abia |  University of Yaounde 1 | Cameroon

Wilfred Angie Abia is an accomplished biochemist and food safety toxicologist whose career bridges Africa and Europe through impactful teaching, research, and international collaborations. His academic foundation in medical biochemistry, nutrition, and toxicology has evolved into a distinguished career specializing in food contaminants, mycotoxin biomonitoring, fraud detection, and risk assessment. He has held influential postdoctoral and leadership positions in projects addressing agri-food safety and consumer health protection. His contributions span mycotoxicology, food fraud prevention, One Health research, and climate-related food safety challenges. Beyond research, he plays an important role as a senior lecturer and mentor, advancing both academic excellence and professional training in food safety.

Profile

Google Scholar
Orcid
Scopus

Early Academic Pursuits

Wilfred Angie Abia began his academic journey with a strong foundation in biochemistry, focusing on medical laboratory technology, nutritional sciences, and food safety. His doctoral studies at the University of Yaoundé I provided him with advanced expertise in food contaminants, safety, and biomonitoring of multimycotoxin exposures. His early academic years were marked by interdisciplinary training that connected biochemistry, nutrition, toxicology, and public health, setting the stage for his specialized career in agri-food safety and toxicology.

Professional Endeavors

His professional career spans teaching, research, and project management across multiple institutions and international collaborations. He has held postdoctoral fellowships and senior research positions in Africa, Europe, and the United Kingdom, where he advanced projects on food safety, toxicology, and fraud detection. His work at Queen’s University Belfast included leadership roles in large-scale European initiatives, where he served as both a researcher and project manager. As a Senior Lecturer of Biochemistry and Food Safety/Toxicology at the University of Yaoundé I, he combines teaching, mentorship, and research with program coordination responsibilities, shaping the next generation of food safety professionals.

Contributions and Research Focus

Abia’s research focuses on food contaminants, safety, and human health with a special emphasis on mycotoxicology. He has pioneered studies in exposure assessment, biomarker development, and human biomonitoring, particularly in vulnerable populations. His work extends to food integrity, authenticity, fraud detection, and traceability, ensuring consumer health protection. He has contributed significantly to toxicological risk assessments of chemicals in food, drugs, and the environment, while also addressing broader themes such as climate change, food security, and the One Health approach. His unique contributions include research into the neurotoxicology of mycotoxins, highlighting the intersection of food safety and neuroscience.

Accolades and Recognition

Throughout his career, Abia has been recognized through prestigious international research fellowships and visiting scholar positions in leading research centers across Europe and Africa. His involvement in high-impact projects such as MycoMarker and FoodSafer underscores his leadership in global food safety initiatives. His achievements are further strengthened by professional certifications, including specialized training in food fraud prevention, which demonstrate his commitment to continuous professional growth and excellence in his field.

Impact and Influence

His work has had a profound impact on advancing food safety research, shaping policies, and protecting public health. By bridging biochemistry with toxicology, agri-food safety, and environmental sciences, he has influenced how food contaminants and fraud are detected and managed. His role as a lecturer and mentor ensures that his expertise is transmitted to students and young researchers who will continue to advance the field. His contributions also extend to policy and science diplomacy, where he actively promotes interdisciplinary collaboration for sustainable solutions in food and health security.

Legacy and Future Contributions

Abia’s legacy lies in his dedication to safeguarding food systems, advancing toxicological research, and promoting interdisciplinary approaches that connect human, animal, and environmental health. His work in mycotoxin biomonitoring and neurotoxicology offers critical insights into the hidden health risks of food contamination. Looking ahead, his future contributions are likely to expand in areas of food fraud prevention, climate-smart agriculture, and One Health frameworks, ensuring resilient food systems for global populations. His combination of research excellence, teaching, and science diplomacy positions him as a thought leader in shaping the future of food safety and toxicology.

Publications

  • Title: Determination of multi-mycotoxin occurrence in cereals, nuts and their products in Cameroon by liquid chromatography tandem mass spectrometry (LC-MS/MS)
    Authors: WA Abia, B Warth, M Sulyok, R Krska, AN Tchana, PB Njobeh, MF Dutton, …
    Year: 2013

  • Title: Mycotoxin exposure in rural residents in northern Nigeria: A pilot study using multi-urinary biomarkers
    Authors: CN Ezekiel, B Warth, IM Ogara, WA Abia, VC Ezekiel, J Atehnkeng, …
    Year: 2014

  • Title: Development and validation of a rapid multi‐biomarker liquid chromatography/tandem mass spectrometry method to assess human exposure to mycotoxins
    Authors: B Warth, M Sulyok, P Fruhmann, H Mikula, F Berthiller, R Schuhmacher, …
    Year: 2012

  • Title: Bio-monitoring of mycotoxin exposure in Cameroon using a urinary multi-biomarker approach
    Authors: WA Abia, B Warth, M Sulyok, R Krska, A Tchana, PB Njobeh, PC Turner, …
    Year: 2013

  • Title: Ultra-sensitive, stable isotope assisted quantification of multiple urinary mycotoxin exposure biomarkers
    Authors: B Šarkanj, CN Ezekiel, PC Turner, WA Abia, M Rychlik, R Krska, M Sulyok, …
    Year: 2018

  • Title: Low doses of mycotoxin mixtures below EU regulatory limits can negatively affect the performance of broiler chickens: A longitudinal study
    Authors: O Kolawole, A Graham, C Donaldson, B Owens, WA Abia, J Meneely, …
    Year: 2020

  • Title: Urinary analysis reveals high deoxynivalenol exposure in pregnant women from Croatia
    Authors: B Šarkanj, B Warth, S Uhlig, WA Abia, M Sulyok, T Klapec, R Krska, …
    Year: 2013

Conclusion

Wilfred Angie Abia’s work exemplifies a rare integration of scientific expertise, international leadership, and educational impact. His contributions to food safety, toxicology, and agri-food research not only safeguard public health but also strengthen global food systems. With his continued focus on innovation, interdisciplinary approaches, and capacity building, he stands as a key figure in shaping the future of food safety science and policy worldwide.

Ramesh Chatragadda | Systems Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Ramesh Chatragadda | Systems Neuroscience | Best Researcher Award

Dr. Ramesh Chatragadda, National Institute of Oceanography, India.

Dr. Ramesh Chatragadda is a leading Indian marine biologist whose academic and professional journey reflects a deep commitment to ocean science. With a strong educational foundation in Marine Biology, he has steadily progressed through research fellowships, national postdoctoral work, and various scientific roles, ultimately becoming a Senior Scientist at the CSIR-National Institute of Oceanography and an Assistant Professor at AcSIR. His research focuses on biological oceanography, marine microbial ecology, and environmental sustainability. Internationally recognized through numerous early-career awards and travel fellowships, Dr. Chatragadda’s work continues to influence marine science both in India and globally. His role as a researcher, mentor, and collaborator underscores his dedication to advancing the understanding of ocean ecosystems.

Profile

Google Scholar

🌟 Strengths for the Best Researcher Award

Dr. Ramesh Chatragadda stands out as a highly deserving candidate for the Best Researcher Award due to his impressive research trajectory and impactful scientific contributions. His specialization in biological oceanography and marine microbial ecology demonstrates a critical understanding of marine ecosystems and environmental sustainability. With a Ph.D. in Marine Biology and a robust professional history at premier institutions like CSIR-NIO, NIOT, and NCCR, he brings both field experience and academic depth to his research.

A major strength lies in his international recognition, having secured multiple prestigious awards and travel grants from global bodies such as COBRA, SCOR, PICES, and the Grantham Foundation. These accolades reflect not only the quality but also the global relevance of his research. Additionally, his dual role as a Senior Scientist and Assistant Professor underlines his capacity to balance innovation, publication, and mentorship. His contributions are actively shaping the future of Indian marine research and building strong international scientific networks.

🔍 Areas for Improvement

While Dr. Chatragadda’s achievements are significant, he may consider expanding his interdisciplinary collaborations further, especially with climate scientists, policy makers, and data modelers to translate research into direct marine conservation policies. Increasing open-access publications, science communication efforts, and involvement in community outreach or citizen science programs could enhance public engagement and increase the societal impact of his work. Additionally, assuming editorial roles in international journals or organizing global symposiums would further cement his position as a thought leader in ocean science.

🎓 Early Academic Pursuits

Dr. Ramesh Chatragadda’s journey into the depths of marine science began with a strong academic foundation. He completed his B.Sc. in 2009 from Acharya Nagarjuna University with a focus on Botany, Zoology, and Chemistry. His passion for the ocean and its living resources led him to pursue an M.Sc. in Marine Biology and Fisheries from Andhra University, graduating in 2011. Driven by an insatiable curiosity about marine ecosystems, he earned his Ph.D. in Marine Biology from Pondicherry University in 2016. These formative years not only refined his academic interests but laid a solid groundwork for his future explorations in biological oceanography.

🧪 Professional Endeavors

Dr. Chatragadda’s professional journey reflects a consistent rise in scientific responsibility and academic excellence. After gaining experience as a Junior and Senior Research Fellow at Pondicherry University, he became a National Postdoctoral Fellow at the Atal Centre for Ocean Science and Technology for Islands under the National Institute of Ocean Technology. His career further advanced with his appointment as Project Scientist-B at the National Centre for Coastal Research. He later joined the CSIR-National Institute of Oceanography (NIO) as a Scientist, and was promoted to Senior Scientist in September 2023. Alongside, he holds the designation of Assistant Professor at the Academy of Scientific and Innovative Research (AcSIR), mentoring the next generation of ocean scientists.

🌊 Contributions and Research Focus

At the heart of Dr. Chatragadda’s career lies his profound commitment to understanding marine life and the ecological complexities of ocean systems. His expertise in biological oceanography allows him to explore the intricate interactions between marine organisms and their environment. He is especially noted for his work in marine microbial ecology, bioluminescence, and the functional dynamics of oceanic biological processes. His research endeavors contribute to sustainable marine resource utilization, climate resilience, and biodiversity conservation in coastal and deep-sea ecosystems.

Publication

1. Multifaceted Applications of Microbial Pigments: Current knowledge, Challenges, and Future Directions for Public Health Implications
L Ramesh, CH., Vinithkumar, N.V., Kirubagaran, R., Venil, C.K. and Dufosse — 2019

2. Ecological and biotechnological aspects of pigmented microbes: a way forward in development of food and pharmaceutical grade pigments
CH Ramesh, L Dufosse — 2021

3. Marine pigmented bacteria: A prospective source of antibacterial compounds
R Ramesh, CH., Vinithkumar, N.V. and Kirubagaran — 2019

4. Applications of Prodigiosin Extracted from Marine Red Pigmented Bacteria Zooshikella sp. and Actinomycete Streptomyces sp.
C Ramesh, NV Vinithkumar, R Kirubagaran, CK Venil, L Dufosse — 2020

5. Marine natural products from tunicates and their associated microbes
CH Ramesh, T Bhushan Rao, R Mohanraju, N Thakur, L Dufossé — 2021

6. Natural substrates and culture conditions to produce pigments from potential microbes in submerged fermentation
CH Ramesh, VR Prasastha, M Venkatachalam, L Dufosse — 2022

7. Toxicity studies of Trichodesmium erythraeum (Ehrenberg, 1830) bloom extracts, from Phoenix Bay, Port Blair, Andamans
S Narayana, J Chitra, SR Tapase, V Thamke, P Karthick, C Ramesh, … — 2014

8. Seaweed potential of Little Andaman, India
CH Karthick, P., Mohanraju. R., Murthy, K.N., Ramesh — 2013

9. Antibacterial activity of certain cephalopods from Andamans, India
R Mohanraju, DB Marri, P Karthick, S Narayana, KN Murthy, C Ramesh — 2013

10. Distribution and diversity of seaweeds in North and South Andaman Island
P Karthick, R Mohanraju, CH Ramesh, KN Murthy, S Narayana — 2013

🏁 Conclusion

In conclusion, Dr. Ramesh Chatragadda demonstrates a rare combination of scholarly excellence, research productivity, and global outreach. His commitment to marine biology, recognized by multiple international honors, positions him as a strong contender for the Best Researcher Award. While a few strategic enhancements could broaden the impact of his work, his existing contributions already reflect a high level of research merit, leadership potential, and long-term vision. Based on his credentials and continued dedication to advancing marine science, he is highly suitable for this prestigious recognition.

Liliana Elena Weimer | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Liliana Elena Weimer | Clinical Neuroscience | Best Researcher Award

Dr.  Liliana Elena Weimer, Center For Global Health Istituto Superiore di Sanita’ Rome, Italy.

Dr. Liliana Elena Weimer is a highly accomplished physician and clinical researcher , where she has risen to the prestigious Level II “First Researcher” position. Her professional focus lies in clinical trials for infectious diseases, particularly HIV and Hepatitis C. She has played a critical role in major national and international research efforts, including collaborations with the U.S. Clinical Trials Group and leadership of the large-scale PITER cohort involving 25,000 HCV patients. She is known not only for her scientific contributions but also for her humanitarian efforts during the COVID-19 emergency. Among her recognitions is the 1st Prize at the 2019 International Congress on Hepatitis C in Seville. Throughout her career, she has exemplified scientific integrity, dedication, and service to public health.

Profile

Google Scholar

🎓 Early Academic Pursuits

Born on December 19, 1965, in Buenos Aires to Italian parents, Dr. Liliana Elena Weimer embraced her dual heritage and committed herself to a life in medicine and research. With Italian citizenship and deep academic determination, she laid the groundwork for her career by studying medicine, ultimately finding her professional home in Italy. Her academic path, though not fully detailed, clearly led her toward a focus on clinical medicine and infectious diseases, with her earliest professional roles marking the beginning of a lifelong engagement in public health and biomedical research. Her intellectual dedication and international roots later became an asset in global research collaborations.

🩺 Professional Endeavors

Dr. Weimer’s distinguished career spans over three decades at the Italian National Institute of Health (ISS), beginning in 1985. Starting as a dedicated clinical physician, she ascended to Level III researcher status by 1990 and continued to grow into higher ranks, culminating in her success in the national Art. 15 competition for the Level II “First Researcher” role in 2022, officially backdated to 2021. Throughout her tenure at ISS, she became a central figure within the Global Health Center in Rome. Known for her tireless commitment, she often described her career not simply as a job but as a “mission,” emphasizing both her personal and professional passion for making a difference in human health.

🧪 Contributions and Research Focus

Specializing in clinical trials, Dr. Weimer has coordinated and participated in numerous groundbreaking studies in HIV and Hepatitis C (HCV). Since the early 1990s, she has collaborated closely with renowned figures such as Prof. Giovanni Rossi, Prof. Stefano Vella, and Prof. Gianni Rezza, contributing to some of the most pivotal HIV antiretroviral therapy trials in history. Her research efforts extended to co-leading and organizing both national and international multicenter clinical trials. Notably, she has been at the forefront of the PITER study, a major nationwide cohort that follows 25,000 patients undergoing HCV treatment—one of the most comprehensive initiatives in Italy in the fight against hepatitis.

🌍 Global Collaborations and Humanitarian Engagement

Her impact extends beyond Italy, thanks to her active involvement with the U.S.-based American Clinical Trials Group on HIV studies. These collaborations have enhanced international understanding and treatment of HIV/AIDS. In addition to her clinical and research commitments, Dr. Weimer also devoted herself to frontline service during the COVID-19 pandemic. Volunteering both with the Civil Protection unit and at Bambino Gesù Children’s Hospital, she demonstrated profound humanitarian values. Her presence during a critical time underscored her belief in serving communities not just from behind a lab desk but also on the ground, directly supporting patients and health systems under strain.

🏅 Accolades and Recognition

Dr. Weimer’s work has been acknowledged at both national and international levels. One of the most prominent recognitions she received was the 1st Prize at the International Congress on Hepatitis C held in Seville in November 2019, a testament to her excellence and influence in the field of infectious disease research. Her achievements are not only measured in accolades but also in the tangible difference her work has made in advancing therapy options and clinical management of chronic viral diseases. Her rise within the ISS and the trust placed in her leadership of major research projects further affirm her standing within the scientific community.

💡 Impact and Influence

Over the course of her extensive career, Dr. Weimer has significantly shaped clinical research strategies in Italy, especially regarding chronic viral infections. Her coordination of thousands of patient cases within structured clinical trials has informed policy decisions and improved treatment protocols nationwide. Her presence at the ISS has also influenced future generations of researchers and clinicians, many of whom benefited from her mentorship, leadership, and example of scientific integrity. Through her rigorous methods and patient-focused approach, she has played a key role in Italy’s standing as a leader in global health research, especially in relation to HIV and HCV.

🔬 Legacy and Future Contributions

Looking forward, Dr. Weimer’s contributions will continue to echo through the fields of virology and clinical medicine. Her involvement in the PITER cohort and other studies has laid down essential groundwork for long-term epidemiological surveillance and patient care strategies. With her appointment as First Researcher, she enters a new chapter of leadership, likely to drive more innovative, patient-centered research initiatives in global health. Her legacy lies not only in her publications or awards but also in the thousands of lives improved by the treatments she helped to test, refine, and implement. The combination of scientific rigor and heartfelt service defines her enduring contribution to modern medicine.

Publication

  • Outcome of sustained virological responders with histologically advanced chronic hepatitis C – TR Morgan, MG Ghany, HY Kim, KK Snow, ML Shiffman, JL De Santo, … – 2010

 

  • Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5‐year follow‐up of 150 patients – SL George, BR Bacon, EM Brunt, KL Mihindukulasuriya, J Hoffmann, … – 2009

 

  • Safety and efficacy of simeprevir/sofosbuvir in hepatitis C–infected patients with compensated and decompensated cirrhosis – V Saxena, L Nyberg, M Pauly, A Dasgupta, A Nyberg, B Piasecki, … – 2015

 

  • Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy – D Persaud, SC Ray, J Kajdas, A Ahonkhai, GK Siberry, K Ferguson, … – 2007

 

  • Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real‐world cohort study – EB Tapper, BR Bacon, MP Curry, DT Dieterich, SL Flamm, LE Guest, … – 2016

 

  • Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with< 50 copies/ml HIV-1 RNA – S Baroncelli, CM Galluzzo, MF Pirillo, MG Mancini, LE Weimer, … – 2009

 

  • Predictors of failure with high-flow nasal oxygen therapy in COVID-19 patients with acute respiratory failure: a multicenter observational study – R Mellado-Artigas, LE Mujica, ML Ruiz, BL Ferreyro, F Angriman, E Arruti, … – 2021

 

  • A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients – M Floridia, R Bucciardini, D Ricciardulli, V Fragola, MF Pirillo, LE Weimer, … – 1999

 

  • Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohort – LA Kondili, F Romano, FR Rolli, M Ruggeri, S Rosato, MR Brunetto, … – 2017

 

  • Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER network – LA Kondili, GB Gaeta, D Ieluzzi, AL Zignego, M Monti, A Gori, A Soria, … – 2017

 

🏁 Conclusion

Dr. Weimer stands as a distinguished figure in the field of global health research, with deep expertise in clinical trials and infectious diseases. Her legacy is marked by landmark contributions to HIV and HCV treatment protocols, influential collaborations, and compassionate public service. Her ongoing work continues to shape public health policy and medical research in Italy and beyond. As she advances in her leadership role at the ISS, her experience, insight, and dedication will remain vital to future innovations in clinical research and global health.